等待开盘 09-23 09:30:00 美东时间
-0.020
-0.45%
On September 12, 2025, Ekso Bionics Holdings, Inc. (the "Company") entered into a Secured Promissory Note and Security Agreement (the "Agreement"), by and among the Company, Ekso Bionics, Inc., a Delaware corporation and
09-18 04:11
Ekso Bionics Holdings - on Sept 12, Enters Secured Promissory Note and Security...
09-18 04:10
Shares of Oxford Industries, Inc. (NYSE:OXM) rose sharply in pre-market trading...
09-11 21:01
今日重点评级关注:花旗:维持Apellis Pharmaceuticals"买入"评级,目标价从41美元升至46美元;杰富瑞:维持Kiniksa Pharmaceuticals"买入"评级,目标价从45美元升至54美元
07-30 09:36
Lake Street analyst Ben Haynor maintains Ekso Bionics Holdings (NASDAQ:EKSO) with a Buy and lowers the price target from $15 to $9.5.
07-30 02:13
EKSO Bionics shares are trading lower after the company reported a Q2 sales mis...
07-29 21:54
Shares of Celestica Inc. (NYSE:CLS) rose sharply in pre-market trading after th...
07-29 18:46
Companies Reporting Before The Bell • Bank of Hawaii (NYSE:BOH) is likely to re...
07-28 16:32
Ekso Bionics Holdings (NASDAQ:EKSO) is set to give its latest quarterly earning...
07-26 03:01
Ekso Bionics Holdings, Inc. will release its second-quarter 2025 financial and business results after the market close on July 28, 2025. Management will host a conference call at 1:30 p.m. PT / 4:30 p.m. ET to discuss the results and recent developments. The call can be accessed via phone by dialing 877-407-6184 (domestic) or 201-389-0877 (international) and will be available live and archived on the Company’s website at www.eksobionics.com under...
07-21 20:45